Will the ASX healthcare shares outperform again in 2020?

ASX healthcare
ASX healthcare

The Blue-chip healthcare stocks were collected by Investors in 2019 that offered higher dividends and cash flows. As a result, CSL Limited (ASX: CSL) delivered returns of 51%, Cochlear Limited (ASX: COH) delivered returns of 32% and ResMed Ltd (ASX: RMD) delivered returns of 39%, respectively, in 2019. But there was also a decrease of share such as ASX 200 jumped by about 20 per cent, while the S&P 500, flowed by 29 per cent.


Now with the decreasing in the borrowing costs, many have also taken benefit of the cheap money to invest in companies, which resulted in driving up share prices to overstressed valuations.

Both were surprisingly strong results considering sessions of panic selling, huge rebounds, and then panic selling again.

Experts allege, considering the ageing population, the Australian healthcare market should see greater demand for age-related tests and treatments this year and beyond. Here are top 3 dividends share to buy in 2020 which are predicted to get a level up is Dicker Data to get level up by 126% and Collins Food to get level up by 79%.